Ignite Creation Date:
2025-12-24 @ 11:06 PM
Ignite Modification Date:
2026-04-08 @ 9:35 PM
Study NCT ID:
NCT00681369
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2008-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NIS-OFR-FAS-2007/1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Francisco Sapunar - Medical Science Director
Old Organization:
AstraZeneca